Los Angeles BioZorb Implant Lawsuits: What Breast Cancer Patients Need to Know

You went through breast cancer treatment expecting to heal. Instead, the small marker your surgeon placed after your lumpectomy caused pain, hard lumps, or complications that led to more surgery. If that’s your story, you’re not alone — and you’re not imagining it. The BioZorb Marker was recalled in 2024, and hundreds of women reported serious problems after it failed to work as promised.

This post explains what happened with the BioZorb implant, the lawsuits that followed, and how California law protects patients harmed by a defective medical device. We’ll keep it clear and honest — no hype, just the information you deserve.

Here’s what you’ll learn:

What the BioZorb Marker is and why it was recalled
The complications patients reported
Where the litigation stands after the 2026 settlement
Who qualified, what damages apply, and the California deadline that matters

Let’s start with the device itself.

What Is the BioZorb Marker?

The BioZorb Marker, made by Hologic Inc., is an implantable device used in breast cancer treatment. After a surgeon removed a tumor during a lumpectomy, the marker was placed at the site to help target radiation therapy and mark the area for future imaging.

The device had two parts:

A bioabsorbable framework made of a plastic material (polylactic acid) that was supposed to dissolve into the body within about a year
Titanium clips meant to stay behind permanently to mark the tissue site

The idea sounded helpful. The device was marketed as an advancement for patients undergoing targeted radiation after a lumpectomy. But for many women, the marker didn’t perform the way it was supposed to.

The BioZorb Marker was designed to dissolve and mark tissue after breast cancer surgery — but many patients say it failed to do either safely.

The 2024 FDA Recall

In October 2024, Hologic issued a voluntary recall of all unused BioZorb Markers, urging doctors to stop implanting the device. The FDA classified it as a Class I recall — the most serious type. That classification means the FDA determined the device could cause serious injury or death.

The recall followed hundreds of complaints and reports of adverse events. According to the FDA, the affected devices could cause:

Pain
Infection
Rash
Device migration — the marker moving out of position
Device erosion — the device breaking through the skin
Seroma — fluid buildup under the skin
Other complications requiring additional treatment

Regulators reported hundreds of injuries tied to the device. Notably, the FDA also stated that BioZorb Markers were never cleared or approved to fill space in tissue or improve cosmetic outcomes — uses some patients say the device was associated with. A Class I recall is the FDA’s most serious warning, and BioZorb earned that classification because of reports of significant patient harm.

The Complications Patients Reported

At the heart of these cases is a simple, painful reality: the device often didn’t dissolve as promised. When the bioabsorbable material lingered — or the marker migrated or broke apart — patients experienced a range of complications.

Reported problems included:

Migration — the device moving from where it was placed
Erosion — the device pushing through the skin
Severe pain — often persistent and worsening with pressure or activity
Infection — sometimes requiring urgent medical care
Seroma — fluid pockets forming around the site
Necrosis — death of surrounding tissue in severe cases
Hard lumps and scarring — masses that could mimic a tumor recurrence
Removal surgery — additional operations to take the device out

For breast cancer survivors, some of these complications carried an extra emotional weight. A hard, unexplained mass can feel terrifyingly like cancer returning — causing real fear and distress on top of the physical pain. When the BioZorb failed to dissolve, patients faced pain, infection, disfigurement, and often another surgery — sometimes fearing their cancer had come back.

Where the Litigation Stands

As reports of complications grew, hundreds of women pursued product liability lawsuits against Hologic. Here’s how the litigation unfolded.

The Massachusetts MDL

Federal BioZorb cases were centralized before Judge Allison D. Burroughs in the U.S. District Court for the District of Massachusetts. Consolidating similar cases before one judge is a common way to handle complex device litigation efficiently, while keeping each patient’s claim separate.

Over the course of the litigation, more than 120 patients filed claims. The court prepared a series of bellwether trials — early “test cases” meant to show how juries might respond to the evidence and help guide the direction of the broader litigation.

The 2026 Global Settlement

Just weeks before the first bellwether trial was set to begin, the court paused litigation deadlines — often a sign that settlement talks are underway. In February 2026, the parties reached a global settlement expected to resolve all pending BioZorb lawsuits.

Importantly, the settlement terms and payout amounts were not publicly disclosed. Confidential settlements are common in device litigation, so the individual figures remain private.

BioZorb cases were centralized in Massachusetts and resolved through a confidential global settlement reached in early 2026.

The Legal Theories Behind the Claims

Understanding why these lawsuits succeeded helps explain how device cases work. Plaintiffs generally relied on three core legal theories.

Design defect. The argument that the BioZorb was unreasonably dangerous because of how it was designed — including a material that often failed to dissolve as intended.
Failure to warn. The claim that Hologic did not adequately warn patients and doctors about known risks like migration, erosion, and non-absorption.
Negligence. The assertion that the company failed to use reasonable care in designing, testing, or monitoring the device.

Plaintiffs also alleged the manufacturer failed to disclose reports of complications and didn’t act quickly enough despite mounting complaints. These are exactly the kinds of allegations that product liability law is built to address. BioZorb claims rested on design defect, failure to warn, and negligence — standard product liability theories for a dangerous device.

How California Product Liability Law Applies

If you live in California, your claim would rest on the state’s strong product liability framework. California recognizes several theories that fit BioZorb cases well.

Strict liability — Under this rule, you often don’t have to prove the manufacturer was careless. You generally need to show the product was defective and that the defect caused your harm. That shifts the focus to the device itself.
Design defect — the argument that the BioZorb was unreasonably dangerous as designed.
Failure to warn — the claim that Hologic didn’t adequately disclose known risks to patients and doctors.

Under strict liability, the central question isn’t whether the company “meant” to cause harm — it’s whether the product was defective and hurt you. For a device that a federal agency recalled as its most serious category, that framework gives injured patients a real path to accountability. California’s strict liability rules let injured patients hold a manufacturer responsible for a defective device without proving carelessness.

Who May Have Qualified for a BioZorb Claim

You may be wondering whether your situation fit. Generally, the people who pursued these claims shared a common experience:

They had a BioZorb Marker or BioZorb LP Marker implanted — typically after a lumpectomy for breast cancer.
They later experienced complications — such as migration, erosion, severe pain, infection, seroma, necrosis, or a device that failed to dissolve.
They needed additional treatment — often surgery to remove the device, or were told they might.

Surviving family members of a patient who died or suffered greatly from complications may also have had options in some circumstances. Because the litigation has now reached a global settlement, new claims are generally no longer being accepted — which is exactly why understanding deadlines and acting promptly matters so much in any device case. Breast cancer patients who had a BioZorb implanted and later suffered complications requiring treatment were the core group who qualified.

What Damages May Be Recoverable

A defective device injury affects far more than one hospital visit. In California product liability cases, injured patients can generally seek compensation for the full scope of their harm, which may include:

Medical expenses — costs for treatment, imaging, and removal surgery, past and future
Lost wages — income missed during recovery and additional procedures
Lost earning capacity — reduced ability to work going forward
Pain and suffering — the physical toll of chronic pain and repeated surgeries
Emotional distress — including the fear and anxiety of thinking cancer may have returned
Disfigurement and scarring — especially significant with breast injuries

The severity and permanence of the harm tend to shape what a claim is worth. Serious complications, multiple surgeries, and lasting effects carry weight the law recognizes. Compensation can cover medical costs, lost income, pain and suffering, emotional distress, and disfigurement — not just the first bill.

A Composite Example: Meet Diane

Diane is not a real client. She’s a composite — a realistic blend of the kinds of cases attorneys see — created to show how a BioZorb claim can come together.

Diane was diagnosed with early-stage breast cancer in her late 50s and had a lumpectomy, during which her surgeon placed a BioZorb Marker to guide her radiation. She was told it would dissolve within about a year. Nearly two years later, she developed a hard, painful lump at the site, along with swelling and recurring irritation. Terrified her cancer had returned, she saw her doctor — who found the marker had never absorbed and had shifted position. She needed surgery to remove it.

Here’s how her situation took shape:

Confirming the device. Her surgical and operative records identified the BioZorb Marker and its placement.
Documenting the harm. Imaging, her removal surgery report, and treatment notes tied her complications to the failed device.
The legal theory. Her claim centered on design defect and failure to warn — that the device didn’t dissolve as promised and the risks weren’t adequately disclosed.
The emotional toll. Her records also reflected the significant distress of fearing a cancer recurrence.

No single fact carried Diane’s case. It was the combination — a clearly identified device, well-documented complications, and a removal surgery — that supported a strong position. A documented device, clear complications, and removal surgery are what typically formed the backbone of a BioZorb claim.

The California Deadline You Can’t Afford to Miss

California sets a firm time limit on these claims. Under the statute of limitations, you generally have two years to file a personal injury or product liability lawsuit. Miss that window, and you can lose the right to pursue compensation entirely — no matter how strong your case might be.

These deadlines can be tricky in device cases. The clock may start when you discovered — or reasonably should have discovered — that the device caused your injury, not necessarily on the date it was implanted. Because that timing is nuanced, having your situation reviewed promptly is always the safest move.

Acting early also protects your evidence. Surgical records, device identification, imaging, and even the explanted device itself can be lost or harder to obtain over time.

If you suspect a medical device harmed you, request your surgical records now and treat the legal clock as already running. California’s two-year deadline is firm, and the discovery date can be complicated — so acting early protects both your rights and your evidence.

Why Choose Walch Law

Being harmed by a device meant to help you heal — during one of the hardest chapters of your life — is a profound betrayal of trust. You shouldn’t have to face medical bills, repeated surgeries, and a complicated legal process alone while you’re focused on your health.

At Walch Law, we help injured people and families across California pursue claims against those responsible for their harm. We work to identify the specific device involved, gather the surgical and medical records that support your claim, connect your injuries to documented product problems, and guide you through each step of the process with care.

We work on a contingency fee basis. You pay nothing out of pocket, and we only collect a fee if we recover compensation for you. There’s no financial risk in finding out where you stand.

Get Your Free Consultation Today

If a BioZorb Marker harmed you or someone you love, understanding what happened is a start — but acting on it matters more. Here’s what to remember:

The BioZorb Marker was recalled in October 2024 as a Class I device — the FDA’s most serious category.
Patients reported migration, erosion, pain, infection, and the need for removal surgery.
The litigation resolved through a confidential global settlement reached in early 2026.
California’s two-year deadline and the discovery rule make prompt action essential.

Contact Walch Law today for a completely free, confidential consultation. Tell us what happened, and we’ll give you an honest assessment of your situation and the next steps that make sense for you.

Call today or reach out online to get started.